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The bacterium Agrobacterium tumefaciens causes crown gall tumor
formation in plants. During infection the bacteria translocate an on-
cogenic piece of DNA (transferred DNA, T-DNA) into plant cells at the
infection site. A number of virulence proteins are cotransported into
host cells concomitantly with the T-DNA to effectuate transforma-
tion. Using yeast as a model host, we find that one of these proteins,
VirD5, localizes to the centromeres/kinetochores in the nucleus of
the host cells by its interaction with the conserved protein Spt4.
VirD5 promotes chromosomal instability as seen by the high-
frequency loss of a minichromosome in yeast. By using both yeast
and plant cells with a chromosome that was specifically marked by a
lacO repeat, chromosome segregation errors and the appearance of
aneuploid cells due to the presence of VirD5 could be visualized
in vivo. Thus, VirD5 is a prokaryotic virulence protein that interferes
with mitosis.
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The plant pathogen Agrobacterium tumefaciens naturally cau-ses crown gall disease in dicotyledonous plants, which is
characterized by the formation of plant tumors at infection sites
(1). During infection, a single-stranded copy of a segment of the
bacterial tumor-inducing (Ti) plasmid, called the “T-strand,” is
transferred and integrated into the host genome (1–3). Expres-
sion of the genes present in this transferred DNA (T-DNA) in
transformed plant cells results in uncontrolled cell division and
development of a crown gall tumor (1). Besides the T-region, the
Ti plasmid embraces an area called the “virulence region,” which
contains a set of genes that are essential for virulence of the
bacterium and which mediate T-DNA processing and its delivery
into host cells (4, 5). Concurrently with the T-strand, some of
these virulence (Vir) proteins, including VirD2, VirE2, VirE3,
VirF, and VirD5, are translocated into plant cells via the VirB
type IV secretion system of the bacterium (6, 7). The trans-
located ssDNA-binding protein VirE2 is thought to coat the
T-strand in the host cell cytoplasm, forming a T-complex that is
protected against nucleases (8, 9). VirE2 also interacts with a
host protein called “VIP1” (10), a transcription factor which
moves to the nucleus as part of the defense response (11), and
this may promote transfer of the T-complex to the nucleus (10, 11).
More recently, however, the importance of VIP1 in transformation
was questioned, as a vip1 mutant was transformed equally well as
the wild type (12). The VirF protein is a host range factor (13)
which contains an F-box and thus may be incorporated into a Skp1-
Cdc53-F-box (SCF) ubiquitin-ligase (E3) complex in the host cells
(14). The VirF SCF complex is thought to promote the proteolytic
degradation of VirE2, VIP1, and some other host proteins in the
nucleus (15, 16). This may lead to uncoating of VIP1 and
VirE2 from the T-strand and facilitate T-DNA integration (16).
Proteolysis of VIP1 may at the same time dampen the defense
response by VIP1 (17). An endogenous F-box protein called
“VBF” present in some host plants such as Arabidopsis thaliana
may take over from VirF, and in such plants VirF is not needed for
transformation (18). The transported VirE3 protein is imported
into the host cell nucleus, where it interacts with pBrp, a TFIIB-like
transcription factor, and stimulates transcription of host genes in-
cluding VBF (19, 20). This explained why the simultaneous deletion
of virF and virE3 led to much stronger attenuation of virulence than
seen in the single mutant (19). The translocated VirD5 protein
consists of 833 amino acids and contains two putative nuclear lo-
calization signals (NLSs), and putative helix–turn–helix and helix–
loop–helix domains (21). The function of VirD5 is still unknown,
but in its absence tumor formation is attenuated (22, 23). It was
reported that VirD5 stabilizes VirF in host cells via mutual in-
teraction (22) but also that VirD5 is a nuclear competitor of VBF
for binding to VIP1 to stabilize VIP1 and VirE2 (23).
We found that VirD5 was toxic for both plant and yeast cells,
which indicated that VirD5 may target a conserved essential
process. By using the yeast Saccharomyces cerevisiae as a model
organism, we established that VirD5 binds to the chromosomal
centromeres/kinetochores in the nucleus by interacting with the
conserved kinetochore-associated protein Spt4. This leads to
growth inhibition and chromosome missegregation in both yeast
and plants and the appearance of aneuploid cells.
Results
VirD5 Inhibits Growth of Plant and Yeast Cells. To obtain more in-
sight into the function of VirD5, we expressed the protein in
A. thaliana. To this end, a binary vector containing the virD5
gene driven by a tamoxifen-inducible promoter was transformed
into A. thaliana via flora dip. Fifteen independent transformed
plants were propagated on kanamycin-selection medium. To test
whether VirD5 can influence plant growth and development,
T2 seeds from each of these lines were germinated on kanamycin
medium to which tamoxifen had been added at 1 μM or 10 μM to
induce the expression of VirD5 or in the absence of tamoxifen.
In the presence of tamoxifen seedlings died within 2 wk, but without
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tamoxifen the transgenic seedlings showed normal growth (Fig. 1A).
This result suggested that VirD5 might target an essential cellular
process. The yeast S. cerevisiae is an excellent model to analyze the
function of bacterial effector proteins that in nature exert their
function in multicellular eukaryotes (24, 25). To determine if we
could take advantage of the yeast system, the virD5 gene was cloned
into a yeast multicopy plasmid behind the galactose-inducible
GAL1 promoter and was transformed into strain BY4743. Trans-
formed cells were grown onMYmedium containing 2% glucose for
3 d, and thereafter colonies were taken from the plates, suspended,
and serially diluted and spotted onto an MY plate containing either
2% glucose (MYglu) or 2% galactose (MYgal), which was in-
cubated for another 3 d. Presence of the VirD5 expression construct
(from several different Agrobacterium strains) prevented growth in
yeast (Fig. 1B), whereas a comparable construct with a frameshift
did not inhibit growth (Fig. 1B). Toxicity depended on the expres-
sion level, which could be modulated by the choice of sugar (in-
ducer) present in the growth medium (Fig. S1). The conservation of
the toxicity allowed us to use yeast genetics to study the underlying
molecular mechanisms. We screened a genomic deletion library for
deletion mutations that suppress the toxic effects of VirD5, as such
suppressors may reveal the identity of the target of VirD5. A high-
copy plasmid containing the virD5 gene under the control of the
GAL1 promoter (pMVHis-VirD5) was transformed into all of the
≈5,000 viable yeast deletion strains. After growing on MYglu plates
for 3 d, colonies were streaked onto MYgal plates and incubated for
an additional 3 d. Most of these transformants could not survive on
MYgal plates due to the toxicity of VirD5, but 33 deletion mutants
showed some growth. Upon reanalysis of these individual deletion
mutants, three still showed (partial) suppression of the toxicity of
VirD5. In two of these mutants, genes (GAL3 and GAL4, re-
spectively) were deleted, compromising the transcriptional activa-
tion of the GAL genes, and thus in these mutants the expression of
VirD5 was prevented, explaining their survival. This also shows the
effectiveness of the selection strategy. The other deletion strain that
showed suppression of the toxicity of VirD5 had a deletion in the
SPT4 gene (Fig. 1 C and D and Fig. S2), the product of which may
be a potential target of VirD5, may stabilize or enhance the level of
VirD5 in the cell, may influence the location of VirD5 in the cell, or
otherwise may be necessary for the toxicity of VirD5. To confirm
that the deletion in this strain was responsible for the suppression of
the toxicity of VirD5, the plasmid isolated from the mutant was
retransformed into wild-type yeast cells. This analysis showed that
the construct encoding VirD5 obtained from the spt4Δ mutant had
kept its toxicity (Fig. S2B). This indicated that the presence of SPT4
was essential for the toxicity of VirD5. Whereas colony formation
on medium containing galactose was prevented in yeast strain
BY4743 expressing VirD5, the isogenic strain with the SPT4 de-
letion formed similar numbers of colonies irrespective of VirD5
expression (Fig. S2C).
Subcellular Localization of VirD5. We fused VirD5 N-terminally
with GFP (GFP-VirD5) to study its localization and expressed it
from the MET25 promoter on a single-copy plasmid in strain
BY4743:HTA2-CFP, in which the nucleus was marked by la-
beling of histone H2A with cyan fluorescence. Cells with the
plasmid could grow when the expression of GFP-VirD5 was
blocked by the presence of methionine and also for a short pe-
riod after removal of methionine. This allowed us to visualize
green fluorescence under a confocal microscope in these cells 1 h
after removal of methionine. While GFP fluorescence was pre-
sent throughout the cell in control cells expressing unfused GFP,
GFP-VirD5 was seen clustered as bright dots in the nucleus (Fig.
2A), indicating that VirD5 is localized at specific foci in the
nucleus. The genome-wide deletion mutants screening indicated
that deletion of SPT4 reduced the toxicity of VirD5. Crotti and
Basrai (26) showed that a Spt4-GFP fusion protein is localized to
three to seven foci in the yeast nucleus, a pattern resembling that
seen with the GFP-VirD5 fusion. Some of the Spt4-GFP foci
have been shown to overlap with kinetochore-containing Ndc10-
HA foci, indicating that a subset of Spt4-GFP foci localize at the
kinetochores, where Spt4 contributes to the formation of the
centromeric chromatin structure and to chromosome trans-
mission fidelity (26). This suggested that VirD5 might similarly
be targeted to centromeres/kinetochores and that its toxicity may
be due to impaired chromosome segregation.
To determine whether VirD5, like Spt4, is localized at the
centromeres/kinetochores, the centromere/kinetochore-associated
proteins Ndc10 and Spt4 were fused N-terminally with CFP in a
construct driven by the MET25 promoter and subsequently
cotransformed with a construct expressing GFP-VirD5 into yeast.
Cells were observed under a confocal microscope 1 h after the
removal of methionine. GFP-VirD5 foci overlapped fully with both
CFP-Spt4 foci and CFP-Ndc10 foci (Fig. 2B), suggesting that
VirD5, like Spt4, is present at the centromeres/kinetochores that
are marked by Ndc10. To test whether VirD5 interacts with Spt4,
we performed bimolecular fluorescence complementation (BiFC)
experiments (27). VirD5 was fused with the C-terminal part of YFP
(VC173) and transformed into BY4743 cells together with Spt4
Fig. 1. VirD5 inhibits the growth of plants and yeast. (A) TransgenicA. thaliana
containing virD5 driven by the tamoxifen-inducible promoter were grown on
MS medium containing different concentrations of tamoxifen or without ta-
moxifen (DMSO). Kanamycin was present to select for seedlings containing
T-DNA. (B) Yeast cells (BY4743) transformed with a high-copy plasmid (pMVHis-
VirD5) encoding VirD5 from different Agrobacterium strains under the control
of the GAL1 promoter. Transformants were fivefold serially diluted and spotted
onto MY selection medium containing either 2% glucose or 2% galactose and
were incubated for 3 d at 30 °C. (C) Identification of spt4Δ as a suppressor of
VirD5 toxicity. A representative portion of the whole genome-wide deletion
collection (∼5,000 strains) was transformed with plasmid (pMVHis-VirD5).
Transformants were first selected on glucose medium and then were streaked
onto galactose plates. (D) Wild type or the spt4Δ-deletion mutant transformed
with a high-copy empty plasmid pMVHis or pMVHis-VirD5. Transformants were
fivefold serially diluted, spotted onto MY selection medium containing either
2% glucose or 2% galactose, and incubated for 4 d at 30 °C.









fused with the N-terminal part of YFP (VN173). As can be seen in
Fig. 3A, VirD5 displayed a very strong BiFC signal with Spt4 in the
nucleus, whereas the fusions of VirD5 or Spt4 introduced together
with the unfused complementary part did not give a BiFC signal. To
confirm this interaction, an in vitro pull-down assay was done with
GST-Spt4 bound to the glutathione HiCap matrix using unfused
GST as a control. The beads were incubated separately with His-
tagged VirD5, and after three washings the protein mixtures were
separated on a 10% SDS/PAGE gel. As shown in Fig. 3B,
VirD5 copurified with GST-tagged Spt4 but not with empty GST,
suggesting that Spt4 binds directly to VirD5.
As deletion of SPT4 suppressed the toxicity of VirD5, we in-
vestigated whether this deletion led to an altered localization
of VirD5. As shown in Fig. 3C GFP fluorescence was present
throughout the nucleus in the spt4Δ-deletion strain, and we could
not find foci in over 90% of transformed cells. Only a few foci were
present in the remaining 10% of transformed cells. Introduction of
a wild-type SPT4 gene into the Δspt4-deletion strain restored the
punctate foci of VirD5 in all the cells (Fig. 3C).
The N-Terminal Part of VirD5 Is Responsible for Targeting to the
Centromeres/Kinetochores. Protein sequence alignment showed
that the N-terminal part of VirD5 contains six degenerate re-
peats, each of which consists of ≈40 amino acids (Fig. S3). To
determine whether these N-terminal repeats are responsible for
targeting to the centromeres/kinetochores in yeast cells, the 505
N-terminal amino acids of VirD5 (VirD5NT) embracing these
six repeats and, as a control, the 313 C-terminal amino acids of
VirD5 (VirD5CT) were fused in frame with GFP and expressed
under the control of the MET25 promoter in wild-type BY4743
cells. After cells were shifted to methionine-free medium for 1 h,
dots were seen in the nuclei of cells expressing GFP-VirD5NT but
not in those expressing GFP-VirD5CT, where the GFP signal was
distributed throughout the cell (Fig. S4A). This indicates that the N
terminus of VirD5 mediates the accumulation at the centromeres/
kinetochores. We also made a construct embracing a smaller
N-terminal part, VirD5 (1–202). In contrast to VirD5 (1–505),
this construct did not accumulate at the centromeres/kinetochores
(Fig. S4A). Subsequently, we verified the growth-inhibitory prop-
erties of constructs encoding VirD5 (1–202) and VirD5 (1–505) in
comparison with full VirD5. As can be seen in Fig. S4B, the ex-
pression of VirD5 (1–505) in BY4743 yeast cells led to growth in-
hibition but did not prevent growth altogether like the full protein,
suggesting that the C-terminal part also contributes to toxicity. The
expression of VirD5 (1–202) did not interfere with growth. To de-
termine whether the toxicity of VirD5NT could be relieved by the
deletion of SPT4, we transformed either a high-copy empty vector
or a vector encoding VirD5NT in either wild-type yeast or the
Δspt4-deletion mutant. In these experiments we used VirD5NT
fused with three nuclear localization signals (VirD5NT-3×NLS),
which was somewhat more toxic than VirD5NT (Fig. S4), probably
because more VirD5 enters into the nucleus. In the absence of
Fig. 2. VirD5 colocalizes with the centromere/kinetochore-associated pro-
teins Spt4 and Ndc10. (A) Yeast cells (BY4743:HTA2-CFP) transformed with
plasmid encoding empty GFP or GFP-VirD5. (B) Yeast cells (BY4743) trans-
formed with plasmid encoding GFP-VirD5 together with plasmid encoding
CFP-Spt4 or CFP-Ndc10. (Scale bars, 5 μm.)
Fig. 3. VirD5 physically interacts with Spt4. (A) Yeast cells (BY4743) trans-
formed with BiFC vectors. 34VCn, the C terminus of YFP (VC173) fused with the
N terminus of the proteins to be tested; 35VNc, the N terminus of YFP (VN173)
fused with the C terminus of the proteins to be tested. (B) 6×His-tagged
VirD5 was incubated with either GST or GST-Spt4 in vitro; after washing, the
presence of 6×His-VirD5 bound to the glutathione HiCap matrix was detected
by anti-His antibody (His-probe antibody; Santa Cruz). (C) The spt4 deletion
mutant was cotransformed with plasmid encoding GFP-VirD5 and a single-copy
empty plasmid pRS315 or plasmid (pRS315-Spt4) encoding wild-type Spt4 with
its own promoter and terminator. (Scale bars, 5 μm.)
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SPT4, VirD5NT-3×NLS was no longer toxic to yeast cells (Fig.
S4C), suggesting that Spt4 is required for VirD5NT-3×NLS to exert
its toxicity. To test whether VirD5NT interacts with Spt4, we carried
out a BiFC assay. As can be seen in Fig. S3B, VirD5NT showed a
clear BiFC signal with Spt4. These data indicate that Spt4 binds to
the N-terminal part of VirD5 and thus localizes it at the centro-
meres/kinetochores, allowing VirD5 to exert its toxic effect at
the centromeres/kinetochores.
VirD5 Causes Chromosome Loss and Missegregation. Centromeres/
kinetochores are key platforms for accurate chromosome seg-
regation during mitosis. In view of its location at the centro-
meres/kinetochores, we wondered whether the presence of
VirD5 affects chromosome segregation and leads to chromo-
some loss. To study this, we used the yeast strain RLY4029 (28),
which contains a minichromosome, CF, harboring the URA3
gene and the SUP11 gene suppressing red pigment accumulation
as a consequence of the chromosomal ade2-101 mutation. Cells
carrying CF produce white colonies, whereas cells lacking CF
form red colonies. RLY4029 cells with and without a construct
encoding VirD5 under the control of the GAL1 promoter
inserted at the LEU2 locus were grown first in minimal medium
containing 2% glucose but lacking uracil, followed by a shift to
yeast extract/peptone (YP) rich medium (with uracil) containing
2% raffinose and 2% galactose for 24 h. The induced cells were
serially diluted and plated on YP rich medium containing 2%
glucose to repress expression of VirD5. As can be seen in Fig.
4A, a >10-fold higher rate of minichromosome loss was observed
in cells expressing VirD5 compared with that in control cells.
These data indicate that VirD5 causes chromosome instability.
To find out whether this is due to chromosome missegregation,
we integrated virD5 driven by the GAL1 promoter into the genome
of the haploid yeast strain Y716 (29). This strain expresses a GFP-
LacI fusion protein that binds to a 256-tandem repeat lacO operator
array integrated into chromosome I of this yeast strain, thus
marking chromosome I with a bright green fluorescent dot inside
the nucleus. After culture for 6 h in the presence of galactose, cells
lacking VirD5 divided normally and showed a single fluorescent dot
in accordance with an equal distribution of chromosome I over the
mother and daughter cell. However, ≈97% of the cells expressing
VirD5 displayed an erroneous distribution of chromosome I over
the mother and daughter cells (Fig. 4B). We found three classes of
missegregation: The major class represented mother cells with two
chromosomes I and daughter cells lacking chromosome I; the sec-
ond class comprised mother cells with chromosome I (one dot) and
daughters lacking chromosome I; and the third class comprised
pairs of cells with a total of more than two bright GFP dots (Fig. 4B).
Chromosome Missegregation in Plants. As Spt4 is a conserved
protein, we tested whether VirD5 also interacted with the two
A. thaliana Spt4 orthologs in BiFC experiments in yeast cells. As
VirD5 indeed also interacted with one of the plant Spt4 ortho-
logs (Fig. S5), we similarly analyzed whether VirD5 could also
affect chromosome segregation in plant cells. To this end, we
used an A. thaliana plant line containing a 256-tandem repeat
lacO operator array integrated into chromosome 5 that could be
visualized under the microscope as a bright green fluorescent dot by
expression of GFP-LacI. The cells also expressed a H2B-DsRed
fusion protein to mark the nucleus with red fluorescence (30).
This chromosome-marked homozygous plant line was crossed with a
Fig. 4. VirD5 disturbs chromosome segregation.
(A) The yeast strain RLY4029 contains an artificial
minichromosome harboring a gene (SUP11) sup-
pressing red pigment accumulation. Loss of this
minichromosome was inferred from the frequency
of red colonies. Error bars represent the mean ± SD
from three independent experiments. (B, Upper) The
yeast strain Y716 contains a 256-repeat lacO array in
chromosome I and expresses GFP-LacI, allowing vi-
sualization of chromosome I by confocal micros-
copy. After integration of a construct encoding
VirD5 under control of the GAL1 promoter into
the genome, cells were cultured in YP medium
containing 2% glucose and then were shifted to
YP medium containing 2% raffinose and 2% ga-
lactose. One hundred mitotic cells with or without
VirD5 were observed. (Lower) Examples and the
numbers of properly and missegregated chromo-
somes in mother/daughter cells are shown. (C) Plant
line 112 is a homozygous plant line in which chro-
mosome 5 contains a construct embracing a 256-re-
peat lacO array as well as genes encoding EGFP-LacI
and H2B-DsRed under the control of RPS5A pro-
moter (pRPS5). “WT” represents the isogenic wild-
type plant line. VirD5 represents a homozygous
transgenic plant line with a construct encoding
VirD5 driven by the tamoxifen-inducible promoter
(pTAM). After crossing, the GFP-marked chromo-
some 5 was visualized by confocal microscopy. Fifty
F1 plants from each crossing line were analyzed.
(Scale bars, 5 μm.) Transformed plants were initially
selected by an NPTII gene driven by the nopaline
synthase (pNOS) promoter. The inserted T-DNA is de-
fined by the left (LB) and right (RB) border repeats.









homozygous transgenic A. thaliana line containing the virD5 gene
driven by the tamoxifen-inducible promoter. F1 seeds of this cross
were germinated on Murashiga and Skoog (MS) medium without
tamoxifen. Subsequently, 4 d after germination, seedlings were
moved to liquid MS medium containing 10 μM tamoxifen and were
incubated for an additional 24 h. During this period the seedlings
still survived. Root cells from the meristematic zone were chosen for
analysis because of their lower background fluorescence, and we
examined roots from 50 individual plants from each cross. As can be
seen in Fig. 4C, root cells from F1 heterozygous plants from a cross
of the lacO/GFP-LacI line with the wild-type plants showed mainly
nuclei with a single bright GFP dot, and, in a few mitotic cells before
cytokinesis, with two dots. In contrast, in root cells from F1 plants
from the cross with the VirD5-expressing line, in addition to many
cells with a single bright dot, cells displaying more than two bright
dots were visible, illustrating chromosome missegregation and gen-
eration of aneuploid cells in plants due to the presence of VirD5.
Discussion
It is known that translocated virulence proteins assist Agro-
bacterium in the process of plant transformation. The functions of
these translocated effector proteins are still not fully understood.
Here we have focused on the VirD5 protein, a relatively large
protein of 833 amino acids with several recognizable domains and
motifs (21). Previously, it was reported that transformation is at-
tenuated in the absence of VirD5 and that VirD5 stabilizes another
translocated effector protein, VirF (22, 23). When we started our
study of VirD5, we found that prolonged VirD5 expression from a
strong promoter was toxic both in plant and in yeast cells and led to
cell death. When expression was restricted in time, cells could re-
cover, and in this way we could study the molecular mechanism of
action of VirD5 in the cell. During transformation in vivo, the dose
of VirD5 translocated into cells is presumably much lower than
after expression from a gene construct in transgenic cells, and due
to natural decay its presence is also limited in time. Therefore, it
is likely that the transient presence of limited amounts of
VirD5 during the initiation phase of tumorigenesis will not be le-
thal but may slow down mitosis. This may be beneficial for trans-
formation by increasing the time window for T-DNA integration.
Our results showed that GFP-VirD5 expression in yeast cells
displayed specific punctate foci in the nucleus (Fig. 2A). A
similar pattern was seen previously in cells expressing a Spt4-
GFP fusion protein (26). As deletion of SPT4 suppressed the
toxicity of VirD5, this motivated our focus on the protein Spt4, a
transcription elongation factor, which forms a heterodimeric
complex with Spt5 to regulate mRNA transcription via direct
interaction with RNA polymerase II (31). The Spt4 protein also
plays a role in chromosome segregation and is a functional and
structural component of centromeric heterochromatin (26, 32).
A gene for this highly conserved protein is present in the human
genome, as well as in that of animals, plants, and other eukary-
otes (33–35). We found that the deletion of SPT4 in yeast re-
duced the toxicity of VirD5 (Fig. 1 C and D and Fig. S2), and the
VirD5 protein was no longer present at the centromeres/kinet-
ochores in most of the cells in this mutant background (Fig. 3C).
Further data demonstrated that VirD5 colocalized and physically
interacted with Spt4 (Figs. 2B and 3 A and B). The centromere
contains a specialized nucleosome that mediates chromosome
attachment via the kinetochore to the spindle microtubule. In
budding yeast, transcription at the centromere induced by the
transcription factor Cbf1, an inner kinetochore protein that
binds directly to the centromeric DNA, facilitates the centro-
mere function (36). However, strong transcription over the
centromere in budding yeast by locating an artificial strong
promoter (GAL1) adjacent to the centromere inactivated its
function, thereby inducing chromosome missegregation and aneu-
ploidy (37). As the VirD5 protein not only is present at centro-
meres/kinetochores by interaction with Spt4 (Fig. 3 A and B) but
also has transcriptional activation activity (23), it is possible that the
toxic effects of VirD5 are (partially) due to erroneous transcription
at the centromeres. We could still see a few nuclear foci in 10% of
the cells deleted for SPT4, suggesting that there may be another
protein at the kinetochore that binds VirD5, although with lower
affinity than Spt4. Loss of these 10% of the cells by cell death would
not be noticed when examining growth in liquid or on plates.
Continued presence of VirD5 leads to chromosome mis-
segregation and aneuploidy, which explains its toxicity and lethal-
ity. Aneuploidy is a hallmark of tumor cells in human and
mammals (38) and is also characteristically seen in plant crown gall
tumor cells (39). However, it remains to be seen whether the levels
of VirD5 transferred during infection are sufficient to induce an-
euploidy. When used for transgenesis, putative aneuploid cells may
not be able to regenerate into plants and therefore are possibly not
seen during Agrobacterium-mediated transformation of plants. Such
cells might, however, contribute to the formation of a crown gall
tumor. It has to be seen whether and how the properties of VirD5
described here are related to the previously described activities re-
lated to stabilization of VIP1 and/or VirF (22, 23). However, VirD5
is a large protein, and, like other virulence proteins such as VirE2, it
may have multiple functions in the transformation process.
Materials and Methods
Primers, Strains, and Plasmids. Primers, strains, and plasmids used in this study
are listed in Tables S1, S2, and S3, respectively.
Plant Material. Binary vector pGPINTAM-VirD5 containing virD5 under the
control of a tamoxifen-inducible promoter was transferred into A. tumefaciens
strain AGL1. A. thaliana ecotype Columbia-0 (Col-0) was used for floral dip
(40). A few weeks after dipping, mature seeds were harvested and sowed on
MS medium [2.3 g/L MS medium including vitamins (Duchefa), 0.5 g/L Mes,
7 g/L agar, pH, 5.8] containing 50 mg/L kanamycin. Kanamycin-resistant
T1 transgenic seedlings were checked for the insert by PCR and trans-
ferred to soil. T2 seeds from 15 independent T1 transgenic plants were
germinated on MS medium containing kanamycin and either DMSO or
different concentrations of tamoxifen (dissolved in DMSO) to induce the ex-
pression of VirD5. Plant line 112, in which chromosome 5 contains a construct
embracing 256 repeats of the lac operator as well as genes encoding EGFP-LacI
and H2B-DsRed under the control of the RPS5A promoter, was obtained from
Antonius Matzke, Gregor Mendel Institute, Vienna.
Subcellular Localization of VirD5 and Its Truncations. Plasmids pUG34GFP,
pUG34GFP-VirD5, pUG34GFP-VirD5 (1–202), pUG34GFP-VirD5NT (1–505),
and pUG34GFP-VirD5CT (521–833) were transformed into yeast BY4743.
Transformants were grown at 30 °C on solid MY medium (41) containing
histidine and leucine and 30 mg/L methionine to suppress the expression of
VirD5 and its truncations. Three days after transformation, colonies were
transferred to MY liquid medium containing 30 mg/L methionine. Overnight
cultures were diluted and grown at 30 °C in fresh MY liquid medium lacking
methionine to induce the expression of VirD5 and its truncations for 1 h. GFP
(excitation, 488 nm; emission, 520 nm) and CFP (excitation, 458 nm; emission
475–515 nm) signals were visualized using a 63× oil objective on a Zeiss
Imager confocal microscope. Images were processed with ImageJ (NIH) and
Photoshop (Adobe).
BiFC Assay. The pUG34VCn-VirD5 plasmid or the empty vector pUG34VCn
were transformed with either the empty pUG35VNc vector or a derivative
with a cloned putative interaction partner into yeast cells. Transformants
were grown at 30 °C on solid MY medium containing 30 mg/L methionine to
inhibit the expression of VirD5. After 3 d colonies were transferred to MY
liquid medium containing methionine. Cells from overnight cultures were
washed twice with water and resuspended in MY medium lacking methio-
nine to induce the expression of VirD5 and other cloned genes. After in-
duction for 1 h, the BiFC signal was analyzed by confocal microscopy
(excitation, 514 nm; emission, 522–532 nm) using a 63× oil objective on a
Zeiss Imager confocal microscope. Images were processed with ImageJ (NIH)
and Photoshop (Adobe).
Chromosome Loss Assay. Strain RLY4029 contains a minichromosome con-
sisting of a fragment of yeast chromosome III with the SUP11 and URA3
marker genes (28). The genetic background of this haploid strain carries an
10242 | www.pnas.org/cgi/doi/10.1073/pnas.1706166114 Zhang et al.
ade2-101 mutation and therefore forms red colonies. The red pigment ac-
cumulation is suppressed by the expression of SUP11 present in the mini-
chromosome, resulting in white colonies. The frequency of loss of this
minichromosome can therefore be calculated by counting the numbers of red
colonies among the total number of colonies. Plasmid pRS305with the virD5 gene
under control of the GAL1 promoter was integrated at the chromosomal LEU2
locus of strain RLY4029, generating strain RLY4029:VirD5 that can grow on MY
with 2% glucose without leucine and uracil. Parental and VirD5-containing yeast
cells were cultured overnight in MY glucose selection medium lacking uracil at
30 °C. Cells were diluted and recultured in MY glucose liquid medium without
uracil for an additional 6 h. After that, cells were diluted 50-fold and switched to
rich medium YP (10 g/L yeast extract, 20 g/L Bacto Pepton) containing 2%
raffinose and 2% galactose for 24 h at 30 °C to induce VirD5. Cells cultured
overnight were diluted to an appropriate density and plated onto rich medium
YP containing 2% glucose for 3 d at 30 °C. Plates were kept at 4 °C for accu-
mulation of red pigment. Total white and red colony numbers were counted.
Chromosome Segregation Assay. Strain Y716 contains a construct encoding
GFP-LacI and a 256-repeat lacO array integrated in chromosome I (29).
Binding of GFP-LacI to the lacO repeats allows the visualization of chro-
mosome I as a GFP dot by microscopy. Y716 and derivatives with a chro-
mosomally integrated plasmid pRS306 construct containing the virD5 gene
driven by the GAL1 promoter were cultured in YP rich medium containing
2% glucose. Cells cultured overnight were diluted to an OD620 of 0.1 and
recultured in YP rich medium containing 2% raffinose and 2% galactose for
an additional 6 h. The GFP signal (excitation, 488 nm; emission, 520 nm) was
observed via a 63× oil objective on a Zeiss Imager confocal microscope. One
hundred mitotic cells were analyzed for each experiment. Images were
processed with ImageJ (NIH) and Photoshop (Adobe).
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